Although the detection of ACPA remains a strong predictor of future RA development, we have previously demonstrated that a substantial proportion of prospectively followed ACPA positive FDR of RA patients do not develop RA, and indeed not uncommonly seroconvert to an ACPA negative state (5). This evidence concerns the gene PRTN3 and rheumatoid arthritis.